Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cholestin suit

This article was originally published in The Tan Sheet

Executive Summary

A decision is expected in late February or early March following oral arguments heard Jan. 7 in Pharmanex' lawsuit against FDA regarding the regulatory status of Cholestin, a red yeast rice product marketed by the company as a dietary supplement for healthy cholesterol. Salt Lake City, Utah federal court Judge Dale Kimball heard the arguments presented on behalf of the company by Williams & Connelly attorney Richard Cooper. The suit was filed by the company to challenge FDA's decision that the product is an unapproved new drug ("The Tan Sheet" May 25, 1998, p. 1)
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089287

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel